LegalizeS.I. No. 583/2014 - Misuse of Drugs (Amendment) (No. 2) Regulations 2014
This is the act as published. Later amendments are not folded into the text below: each one is a separate act in this repository and an entry in this law's history.
1 amending act · 2017-05-05, S.I. No. 173/2017 - Misuse of Drugs Regulations 2017
Notice of the making of this Statutory Instrument was published in
“Iris Oifigiúil” of 26th December, 2014.
I, LEO VARADKAR, Minister for Health, in exercise of the powers conferred on me by sections 4 , 5 (as amended by section 4 of the Irish Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)), 18 and 38 of the Misuse of Drugs Act 1977 (No. 12 of 1977), hereby make the following regulations:
1.
(1) These Regulations may be cited as the Misuse of Drugs (Amendment) (No. 2) Regulations 2014.
- (2) The collective citation “the Misuse of Drugs Regulations 1988 to 2014” includes these Regulations.
2.
In these Regulations “Principal Regulations” means the Misuse of Drugs Regulations 1988 ( S.I. No. 328 of 1988 ).
3.
Paragraph 1(a) of Schedule 1 (as amended by Regulation 5 of the Misuse of Drugs (Amendment) Regulations 2014 ( S.I. No. 323 of 2014 )) to the Principal Regulations is amended—
- (a) by inserting “5-(2-Aminopropyl) indole (otherwise known as 5-IT).” before “1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-pentanone.”,
- (b) by inserting “3,4-dichloro-N-[[1-(dimethylamino) cyclohexyl]methyl]benzamide (otherwise known as AH-7921).” after “Concentrate of poppy-straw.”,
- (c) by inserting “4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl) phenethylamine (otherwise known as 25I-NBOMe).” after “[9-Hydroxy-6-methyl-3-[5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl] acetate.”, and
- (d) by inserting “2-(3-methoxyphenyl)-2-(ethylamino) cyclohexanone (otherwise known as methoxetamine).” after “Methcathinone.”.
4.
Paragraph 6 of Schedule 2 (as amended by Regulation 6 of the Misuse of Drugs (Amendment) Regulations 2014) to the Principal Regulations is amended by inserting “4-Hydroxybutanoic acid (otherwise known as gamma-hydroxybutyric acid (GHB)).” after “Glutethimide.”.
5.
Paragraph 1(a) of Schedule 3 (as amended by Regulation 5 of the Misuse of Drugs (Amendment) Regulations 2011 ( S.I. No. 552 of 2011 )) to the Principal Regulations is amended by deleting “4-Hydroxybutanoic acid.”.
GIVEN under my Seal,
17 December 2014.
LEO VARADKAR,
Minister for Health.
EXPLANATORY NOTE
(This note is not part of the Instrument and does not purport to be a legal interpretation.)
The purpose of these Regulations is to amend the Misuse of Drugs Regulations 1988. The Regulations of 1988 apply controls to the groups of drugs specified in Schedules 1 to 5 of the Regulations (being drugs to which the Misuse of Drugs Acts 1977 and 1984 apply), the effect of which is to impose restrictions on the production, supply, importation and exportation of the drugs in question, which vary according to the extent to which these drugs are used for medical or scientific purposes and having regard to the likelihood of their being abused.
These Regulations amend the Misuse of Drugs Regulations 1988 by adding certain additional substances to Schedule 1 of the Regulations, and increasing the extent of the controls applicable to 4-Hydroxybutanoic acid.
These Regulations may be cited as the Misuse of Drugs (Amendment) (No. 2) Regulations 2014.
This document does not substitute the official text published in the Irish Statute Book. We accept no responsibility for any inaccuracies arising from the transcription of the original into this format.
This text is published under Irish Statute Book's own terms of reuse, not a Legalize or public-domain licence.
Irish Statute Book
CC-BY 4.0 (Oireachtas Open Data PSI Licence)
Contains Irish Public Sector Information licensed under the Oireachtas (Houses of the Oireachtas) Open Data PSI Licence / Creative Commons Attribution 4.0 International, sourced from https://www.irishstatutebook.ie.